NetworkNewsBreaks – Trxade Group Inc.’s (TRXD)
Post# of 174
(Total Views: 188)
Posted On: 07/26/2019 5:16:38 PM
NetworkNewsBreaks – Trxade Group Inc.’s (TRXD) Web Platform Protects Profit Margins, Cuts Negative Reimbursement Costs
Integrated pharmaceutical logistical services company Trxade Group (OTCQB: TRXD) hosts a supplier-to-pharmacy (“S2P”) pharmaceuticals trading platform that is helping pharmacists protect their profit margins by evading negative reimbursement costs. An article discussing Trxade Group reads, “In the vast economic sector that is the U.S. pharmaceutical industry — $330+ billion a year — proprietors of independent pharmacies, many of whom are constrained in terms of time and resources, run $3.5 million-per-annum operations while struggling to maintain margins. In the past, they have turned to GPOs and other sourcing programs to reduce the purchase cost of drugs, which the GPOs were supposed to accomplish through the consolidation of buying power. The proof of the pudding, however, is in the eating. Over the past decade, independent pharmacies have been experiencing declining margins due to rising fees and reduced reimbursements from pharmacy benefit managers (PBMs) and volatility in drug costs.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Integrated pharmaceutical logistical services company Trxade Group (OTCQB: TRXD) hosts a supplier-to-pharmacy (“S2P”) pharmaceuticals trading platform that is helping pharmacists protect their profit margins by evading negative reimbursement costs. An article discussing Trxade Group reads, “In the vast economic sector that is the U.S. pharmaceutical industry — $330+ billion a year — proprietors of independent pharmacies, many of whom are constrained in terms of time and resources, run $3.5 million-per-annum operations while struggling to maintain margins. In the past, they have turned to GPOs and other sourcing programs to reduce the purchase cost of drugs, which the GPOs were supposed to accomplish through the consolidation of buying power. The proof of the pudding, however, is in the eating. Over the past decade, independent pharmacies have been experiencing declining margins due to rising fees and reduced reimbursements from pharmacy benefit managers (PBMs) and volatility in drug costs.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)